Purchase Order 75N91024P00306
- Not listed
- This is a $35,239.68 firm fixed price delivery order awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to Deutsches Krebsforschungszentrum (DKFZ), a non-profit cancer research organization based in Germany. The contract is for HPV serology testing services, which aligns with DKFZ's expertise in cancer research, diagnostics, and testing. The contract does not have a set-aside designation, indicating it was awarded through open competition....
- This is a firm fixed-price delivery order awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Deutsches Krebsforschungszentrum (DKFZ), a non-profit organization based in Germany. The contract is for "OTHER FUNCTIONS OPTION PERIOD ONE (1): ADDITIONAL SAMPLES FOR HPV SEROLOGY" with a ceiling value of $37,407.15. The contract does not have a set-aside designation, indicating open competition. DKFZ, also known as Dkfz, is...
- This firm fixed-price purchase order was awarded by the National Cancer Institute, part of the National Institutes of Health within the Department of Health and Human Services, to the non-profit organization Deutsches Krebsforschungszentrum (DKFZ) to provide multiplex serology testing of antigens for plasma samples. The $119,840 contract is intended to assist with understanding Epstein-Barr virus (EBV) antibody-based nasopharyngeal cancer (NPC) risk scores in Asian population cohorts. The...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services, National Institutes of Health, National Cancer Institute to Deutsches Krebsforschungszentrum (DKFZ), a non-profit organization and foundation, to conduct a study testing for possible relationships between gynecologic infections and endometrial cancer in serum samples from a previous study in Poland. The potential value of the contract is $105,816.00, and the period of performance runs from the award...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm-fixed-price purchase order to Deutsches Krebsforschungszentrum (DKFZ), a non-profit organization and foundation, to provide services for the collection, harmonization, and management of breast cancer risk factor data being contributed to the Confluence Project from the Breast Cancer Association Consortium (BCAC). The base period of performance for this contract is from September...
- This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to Universitaetsklinikum Essen Anstalt DES Oeffentlichen Rechts, a hospital and non-profit organization in Germany. The contract, valued at $84,525.00, is part of the NCI Cancer Genome Atlas Program and supports the collection of tissue samples and data from various types of cancer. The contract is not designated as a set-aside. Universitaetsklinikum Essen has previously received federal grant subawards from...
- <p>The National Cancer Institute awarded a purchase order to Zellmechanik Dresden GMBH for $120,000 on August 4, 2020, for procurement of the Accelerator for Probing the Biophysical Regulation of Metastasis. Performance will take place in Germany. The order carries a firm fixed price and was issued without a set-aside. The ultimate completion date is November 17, 2020. The procurement originated from a special notice posted June 15, 2020, with a closing date of June 25, 2020.</p>
- The federal contract award is for a "Patterns of Care/Quality of Care Study (POC): Diagnosis Year 2016" to be performed by the Fred Hutchinson Cancer Research Center, a non-profit organization. The contract has a ceiling value of $75,367.00 and was awarded on July 31, 2017 by the National Cancer Institute, a civilian agency within the Department of Health and Human Services. The contract is a firm fixed price delivery order, with an ultimate completion date of July 30, 2018. This...
- This is a firm fixed price purchase order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services, to Engene Statistics GMBH, doing business as Engene Statistics Sagl, a for-profit organization based in Switzerland. The $23,530.37 contract is for laboratory testing services to support biomedical research projects involving high throughput data analysis, particularly in the field of cancer...
- Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. and Federally Funded Research and Development Center contractor, received a $56.5 million cost-plus-fixed-fee delivery order from the National Cancer Institute to develop target characterization methods for novel cancer markers. The contract, awarded September 28, 2020, with an ultimate completion date of May 25, 2027, will be performed at Leidos' Frederick, Maryland facility. No set-aside designation was used for this award....
This $507,000 firm-fixed-price purchase order was awarded by the National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, to Deutsches Krebsforschungszentrum (DKFZ), a German non-profit organization focused on cancer research. The contract requires DKFZ to test no more than 13,000 samples previously collected in the Anchor Trial using a multiplex serology assay of up to 41 antigens. The work is to be performed at DKFZ's facilities in Heidelberg, Germany, with a completion date of April 30, 2026. This contract did not have a set-aside designation, indicating open competition. DKFZ has a history of providing specialized cancer research services, including testing, data analysis, and expertise, to various U.S. federal agencies through both contracts and grants.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 4/30/25 | |
| Not listed | Not listed | $507.0k | 3/15/24 |